NCT05145127: Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- State
- Under way
- Phase
- Phase 3
- People
- 245 planned
- Started
- 17 Nov 2021
- Primary completion
- 31 Jul 2030
- Arms
- PF-06741086
- Results
- None posted
- 17 Nov 2021: Trial started
- 6 Dec 2021: Trial registered